A Study To Evaluate A Booster Dose Of Menacwy-tt Vaccine Administered 10 Years After Healthy Subjects Aged 11-17 Years Received Either Menacwy-tt Vaccine (Nimenrix(Registered)) Or Mencevax Acwy(Registered).

PHASE3CompletedINTERVENTIONAL

Enrollment

229

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

April 11, 2018

Study Completion Date

April 11, 2018

Conditions

Meningococcal ACWY Disease

Interventions

BIOLOGICAL

MenACWY-TT

Single dose of MenACWY-TT given 10 years after first vaccine with either MenACWY-TT or Mencevax ACWY

Trial Locations (1)

Research Institute for Tropical Medicine, Muntinlupa City